PCM
PGEN icon

Palisade Capital Management’s Precigen PGEN Stock Holding History

Palisade Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,463
Closed -$275K – 507
2014
Q4 		$275K Buy
+10,463
New +$229K 0.01% 454

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Palisade Capital Management's PGEN Position: Q1 2015 in Review

Palisade Capital Management sold out of Precigen (PGEN) in Q1 2015, closing a stake of 10,463 shares — an estimated $275K sold.

Palisade Capital Management first reported a position in PGEN in Q4 2014 and held it in 1 quarter. The position peaked at $275K in Q4 2014. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2015.

  • Palisade Capital Management reported no remaining Precigen position as of Q1 2015 after selling out during the quarter.
  • Palisade Capital Management sold 10,463 Precigen shares in Q1 2015, an estimated $275K.
  • Palisade Capital Management first reported a position in Precigen in Q4 2014 and held it in 1 quarter.
  • Palisade Capital Management's Precigen position peaked at $275K in Q4 2014.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q1 2015.

Based on Palisade Capital Management's 13F filing for Q1 2015, filed 13 May 2015.